登录 注册 会员服务 联系我们

Myasthenie bei Erwachsenen, Kindern und Jugendlichen – was ist neu?

  • Published:2023-03-30 Issue:6 Volume:94 Page:501-509
  • ISSN:0028-2804
  • Container-title:Der Nervenarzt
  • language:de
  • Short-container-title:Nervenarzt

Author:

Stascheit Frauke,Della Marina Adela,Meisel Andreas

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology,General Medicine

Reference37 articles.

1. Nowak RJ, Coffey CS, Goldstein JM, Dimachkie MM, Benatar M, Kissel JT, Wolfe GI, Burns TM, Freimer ML, Nations S, Granit V, Smith AG, Richman DP, Ciafaloni E, Al-Lozi MT, Sams LA, Quan D, Ubogu E, Pearson B, Sharma A, Yankey JW, Uribe L, Shy M, Amato AA, Conwit R, O’Connor KC, Hafler DA, Cudkowicz ME, Barohn RJ; NeuroNEXT NN103 BeatMG Study Team (2021) Phase 2 trial of rituximab in acetylcholine receptor antibody-positive generalized myasthenia gravis: the BeatMG study. Neurology 98(4):e376–e389. https://doi.org/10.1212/WNL.0000000000013121

2. Piehl F, Eriksson-Dufva A, Budzianowska A, Feresiadou A, Hansson W, Hietala MA, Håkansson I, Johansson R, Jons D, Kmezic I, Lindberg C, Lindh J, Lundin F, Nygren I, Punga AR, Press R, Samuelsson K, Sundström P, Wickberg O, Brauner S, Frisell T (2022) Efficacy and safety of rituximab for new-onset generalized myasthenia gravis: the RINOMAX randomized clinical trial. JAMA Neurol 79(11):1105–1112. https://doi.org/10.1001/jamaneurol.2022.2887

3. Barth D, Nabavi NM, Ng E et al (2011) Comparison of IVIg and PLEX in patients with myasthenia gravis. Neurology 76:2017–2023

4. Benfaremo D, Manfredi L, Luchetti MM et al (2018) Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: a review of the literature. CDS 13:150–164

5. Brauner S, Eriksson-Dufva A, Hietala MA et al (2020) Comparison between Rituximab treatment for new-onset generalized myasthenia Gravis and refractory generalized myasthenia gravis. JAMA Neurol 77:974–981

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Milestones in the history of neurocritical care;Neurological Research and Practice;2023-08-10
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3